Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Brain Waves01:23

Brain Waves

Brain waves are electrical signals generated by the neurons in the brain, which are regularly monitored to measure mental activities. Brain waves and their frequency ranges can be measured using an electroencephalogram or EEG. There are four main types of brain waves, each with distinct characteristics:
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Thirty-eight-negative kinase 1 (TNK1) facilitates TNFalpha-induced apoptosis by blocking NF-kappaB activation.

Oncogene·2007
Same author

[Palliative treatment of pancreatic cancer].

Deutsche medizinische Wochenschrift (1946)·2007
Same author

[Reflux-associated nutcracker oesophagus in a 49-year-old patient with non-cardiac chest pain (NCCP)].

Zeitschrift fur Gastroenterologie·2007
Same author

Bile synthesis in rat models of inflammatory bowel diseases.

European journal of clinical investigation·2007
Same author

[Outcome quality of gerontopsychiatric day-clinic treatment: changes in life-satisfaction:].

Psychiatrische Praxis·2007
Same author

[Fulminant pancreatitis--internal point of view].

Praxis·2006

Related Experiment Video

Updated: Jul 12, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

EEG coherence in Alzheimer's dementia.

G Adler1, S Brassen, A Jajcevic

  • 1Clinical Neurophysiology Service, Central Institute of Mental Health, Mannheim, Germany. adler@zi-mannheim.de

Journal of Neural Transmission (Vienna, Austria : 1996)
|August 21, 2003
PubMed
Summary

Electroencephalography (EEG) alpha coherence may help diagnose Alzheimer's dementia (AD). Reduced left temporal alpha coherence and increased global theta power in EEG can identify AD patients with high accuracy.

More Related Videos

Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
08:25

Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans

Published on: May 19, 2016

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Related Experiment Videos

Last Updated: Jul 12, 2026

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease
11:01

Examining the Characteristics of Episodic Memory using Event-related Potentials in Patients with Alzheimer's Disease

Published on: August 30, 2011

Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans
08:25

Combined Invasive Subcortical and Non-invasive Surface Neurophysiological Recordings for the Assessment of Cognitive and Emotional Functions in Humans

Published on: May 19, 2016

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
09:38

Generalized Psychophysiological Interaction (PPI) Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease

Published on: November 14, 2017

Area of Science:

  • Neuroscience
  • Neurology
  • Biomedical Engineering

Background:

  • Alzheimer's dementia (AD) is characterized by axonal disruption and cholinergic deficits, leading to impaired cortical connectivity and reduced EEG alpha coherence.
  • Quantitative EEG analysis offers a potential non-invasive method for assessing brain function and diagnosing neurological conditions.

Purpose of the Study:

  • To evaluate the diagnostic utility of electroencephalography (EEG) coherence parameters for identifying Alzheimer's dementia (AD).
  • To determine if specific EEG patterns can differentiate AD patients from cognitively unimpaired controls.

Main Methods:

  • Quantitative EEG analysis was conducted on 31 AD patients and 17 healthy controls without psychopharmacological treatment.
  • Statistical analyses, including stepwise logistic regression, were used to assess the diagnostic significance of EEG parameters.

Main Results:

  • AD patients exhibited increased global theta power and decreased left temporal alpha coherence and interhemispheric theta coherence compared to controls.
  • Left temporal alpha coherence and global theta power achieved 87% sensitivity and 77% specificity in identifying AD patients.

Conclusions:

  • Quantitative EEG analysis, particularly left temporal alpha coherence, shows promise in enhancing the diagnostic capabilities for Alzheimer's dementia.
  • EEG coherence parameters may serve as valuable biomarkers for the early and accurate diagnosis of AD.